Prestige Consumer Healthcare Inc. (PBH): Free Cash Flow
$246.45M
Year ended 2026-03-31
$235.36M
Trailing 12 months to 2026-06-30
+3.6%
3-year compound annual growth
+2.9%
5-year compound annual growth
+3.6%
10-year compound annual growth
| Period ended | Free Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2026-03-31 | $246.45M | +1.3% | 2026-05-14, From 2025-04-01 |
| 2025-03-31 | $243.29M | +1.6% | 2026-05-14, From 2024-04-01 |
| 2024-03-31 | $239.38M | +7.9% | 2026-05-14, From 2023-04-01 |
| 2023-03-31 | $221.93M | -11.3% | 2025-05-09, From 2022-04-01 |
| 2022-03-31 | $250.28M | +17.3% | 2024-05-15, From 2021-04-01 |
| 2021-03-31 | $213.36M | +5.3% | 2023-05-05, From 2020-04-01 |
| 2020-03-31 | $202.56M | +13.3% | 2022-05-06, From 2019-04-01 |
| 2019-03-31 | $178.80M | -9.5% | 2021-05-07, From 2018-04-01 |
| 2018-03-31 | $197.58M | +35.6% | 2020-05-08, From 2017-04-01 |
| 2017-03-31 | $145.69M | -15.7% | 2019-05-13, From 2016-04-01 |
| 2016-03-31 | $172.74M | n/c | 2018-05-10, From 2015-04-01 |
| 2015-03-31 | $150.15M | +38.0% | 2017-05-17, From 2014-04-01 |
| 2014-03-31 | $108.82M | -14.5% | 2016-05-17, From 2013-04-01 |
| 2013-03-31 | $127.34M | +90.5% | 2015-05-14, From 2012-04-01 |
| 2012-03-31 | $66.85M | -22.3% | 2014-05-19, From 2011-04-01 |
| 2011-03-31 | $86.02M | +46.4% | 2013-05-17, From 2010-04-01 |
| 2010-03-31 | $58.75M | n/a | 2012-05-18, From 2009-04-01 |
Free Cash Flow at similar companies
| Company | Year ended | Free Cash Flow | Change YoY |
|---|---|---|---|
| Prestige Consumer Healthcare Inc. (PBH) | 2026-03-31 | $246.45M | +1.3% |
| Acadia Pharmaceuticals Inc (ACAD) | 2025-12-31 | $105.15M | -33.1% |
| Madrigal Pharmaceuticals, Inc. (MDGL) | 2025-12-31 | -$190.02M | n/m |
| Indivior Pharmaceuticals, Inc. (INDV) | 2025-12-31 | -$93.00M | n/m |
| Ionis Pharmaceuticals Inc (IONS) | 2025-12-31 | -$320.03M | n/m |
| ANI Pharmaceuticals Inc (ANIP) | 2025-12-31 | $171.39M | +258.7% |
| Harmony Biosciences Holdings, Inc. (HRMY) | 2025-12-31 | $347.89M | +59.1% |
| Arrowhead Pharmaceuticals, Inc. (ARWR) | 2025-09-30 | $156.89M | n/m |
| Alkermes plc. (ALKS) | 2025-12-31 | $480.33M | +18.4% |
Compare PBH, ACAD, MDGL, INDV side by side · Screen every company in Pharmaceutical Preparations ↗